LOS ANGELES, Nov. 02, 2016 -- BlackLine, Inc. (Nasdaq:BL), a leading provider of financial controls and automation solutions that enable Continuous Accounting, today announced the closing of its initial public offering of 9,890,000 shares of its common stock at a price to the public of $17.00 per share, which includes the exercise in full of the underwriters’ option to purchase an additional 1,290,000 shares. Net proceeds from the offering are expected to be $151.7 million, after deducting underwriting discounts and commissions and estimated offering expenses. The shares began trading on the NASDAQ Global Select Market under the ticker symbol “BL” on October 28, 2016.
Goldman, Sachs & Co. and J.P. Morgan acted as joint book-running managers and Pacific Crest Securities, a division of KeyBanc Capital Markets, Raymond James, William Blair and Baird acted as co-managers for the offering.
A registration statement relating to these securities was filed with the SEC and was declared effective on October 27, 2016. The offering was made only by means of a prospectus. Copies of the final prospectus related to the offering may be obtained from Goldman Sachs & Co., Attn: Prospectus Department, 200 West Street, New York, NY 10282, by telephone at (866) 471-2526, by facsimile at (212) 902-9316 or by email at [email protected]; or J.P. Morgan Securities LLC, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, by telephone at (866) 803-9204 or by email at [email protected].
Investor Relations Contact: The Blueshirt Group Christine Greany 858.523.1732 [email protected] Media Relations Contact: The Blueshirt Group Jeff Fox 415.828.8298 [email protected]


BlackRock-Backed Global Ports Deal Faces Uncertainty Amid Cosco Demands
FDA Approves Mitapivat for Anemia in Thalassemia Patients
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
Italy Fines Apple €98.6 Million Over App Store Dominance
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
Boeing Wins $2.04B U.S. Air Force Contract for B-52 Engine Replacement Program
Texas App Store Age Verification Law Blocked by Federal Judge in First Amendment Ruling
Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market
BP Nears $10 Billion Castrol Stake Sale to Stonepeak
Hanwha Signals Readiness to Build Nuclear-Powered Submarines at Philly Shipyard for U.S. Navy
Waymo Plans Safety and Emergency Response Upgrades After San Francisco Robotaxi Disruptions
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio
Warner Bros. Discovery Shares Slide Amid Report of Potential Paramount Skydance Lawsuit
Nvidia and Groq Strike Strategic AI Inference Licensing Deal 



